<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Effects of an aged garlic extract and its thioallyl components on rat <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> were examined using a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model and a transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model </plain></SENT>
<SENT sid="1" pm="."><plain>In focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, an aged garlic extract, S-<z:chebi fb="0" ids="30361">allyl</z:chebi> cysteine (SAC), <z:chebi fb="0" ids="30361">Allyl</z:chebi> <z:chebi fb="1" ids="15138">sulfide</z:chebi> (AS) or <z:chebi fb="0" ids="4488">Allyl disulfide</z:chebi> (ADS) was administered 30 min prior to ischemic insult </plain></SENT>
<SENT sid="2" pm="."><plain>Three days after ischemic insult, water contents of both ischemic and contralateral hemispheres were measured to assess the degree of ischemic damage </plain></SENT>
<SENT sid="3" pm="."><plain>The water content of the ischemic control (no drug treatment) group was 81.50 +/- 0.07% (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>It was significantly reduced with the administration of 300 mg/kg of SAC; the water content was 80.66 +/- 0.11% (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The histological observation using 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining demonstrated that the administration of SAC reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="6" pm="."><plain>Neither AS nor ADS was effective </plain></SENT>
<SENT sid="7" pm="."><plain>In global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the production of reactive oxygen species (ROS) was measured ex vivo using a spin-trapping agent, alpha-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-N-tert-butylnitrone, and electron paramagnetic resonance spectroscopy </plain></SENT>
<SENT sid="8" pm="."><plain>The production of ROS had two peaks; first at 5 min and second at 20 min after reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>Both SAC and 7-<z:chebi fb="13" ids="29785">nitro</z:chebi> <z:chebi fb="0" ids="36669,36671">indazole</z:chebi>, a nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase inhibitor, did not attenuate the amount of ROS produced at the first peak, but did the amount of the second peak </plain></SENT>
<SENT sid="10" pm="."><plain>A possible involvement of peroxinitrite, which may be formed from <z:chebi fb="1" ids="18421">superoxide</z:chebi> and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and is known to be highly toxic in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury of the brain, was suggested </plain></SENT>
</text></document>